Exact Sciences Corp (EXAS)
63.24
-0.62
(-0.97%)
USD |
NASDAQ |
Apr 17, 16:00
63.21
-0.03
(-0.05%)
After-Hours: 20:00
Exact Sciences Cash from Financing (Quarterly): 10.04M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.04M |
| September 30, 2023 | 0.092M |
| June 30, 2023 | 16.04M |
| March 31, 2023 | 133.60M |
| December 31, 2022 | 10.10M |
| September 30, 2022 | 0.235M |
| June 30, 2022 | 63.41M |
| March 31, 2022 | 2.735M |
| December 31, 2021 | -12.20M |
| September 30, 2021 | 0.081M |
| June 30, 2021 | 13.34M |
| March 31, 2021 | 7.245M |
| December 31, 2020 | 879.86M |
| September 30, 2020 | 4.158M |
| June 30, 2020 | 16.12M |
| March 31, 2020 | 979.48M |
| December 31, 2019 | 6.624M |
| September 30, 2019 | 0.98M |
| June 30, 2019 | 5.451M |
| March 31, 2019 | 240.13M |
| December 31, 2018 | 9.354M |
| September 30, 2018 | 19.07M |
| June 30, 2018 | 233.28M |
| March 31, 2018 | 672.44M |
| December 31, 2017 | 2.718M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.46M |
| June 30, 2017 | 255.78M |
| March 31, 2017 | 0.003M |
| December 31, 2016 | 3.366M |
| September 30, 2016 | 144.71M |
| June 30, 2016 | 1.267M |
| March 31, 2016 | 0.247M |
| December 31, 2015 | 2.509M |
| September 30, 2015 | 174.17M |
| June 30, 2015 | 4.795M |
| March 31, 2015 | 0.295M |
| December 31, 2014 | 105.86M |
| September 30, 2014 | 0.136M |
| June 30, 2014 | 138.02M |
| March 31, 2014 | 0.002M |
| December 31, 2013 | 0.236M |
| September 30, 2013 | 0.636M |
| June 30, 2013 | 73.88M |
| March 31, 2013 | 0.008M |
| December 31, 2012 | 0.558M |
| September 30, 2012 | 57.98M |
| June 30, 2012 | 0.222M |
| March 31, 2012 | 1.642M |
| December 31, 2011 | 27.34M |
| September 30, 2011 | 0.331M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-12.20M
Minimum
Dec 2021
979.48M
Maximum
Mar 2020
112.49M
Average
7.245M
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
| Illumina Inc | -27.00M |
| Quest Diagnostics Inc | 130.00M |
| Laboratory Corp of America Holdings | -446.50M |
| Guardant Health Inc | 90.57M |
| Natera Inc | 6.845M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 69.55M |
| Cash from Investing (Quarterly) | -66.77M |
| Free Cash Flow | 31.93M |
| Free Cash Flow Per Share (Quarterly) | 0.1912 |
| Free Cash Flow to Equity (Quarterly) | 33.27M |
| Free Cash Flow to Firm (Quarterly) | 42.40M |
| Free Cash Flow Yield | 0.28% |